{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:31:22Z","timestamp":1788305482446,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T00:00:00Z","timestamp":1526774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T00:00:00Z","timestamp":1526774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1111\/jcpt.12715","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T05:03:58Z","timestamp":1526879038000},"page":"467-475","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review"],"prefix":"10.1155","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7385-3010","authenticated-orcid":false,"given":"A. K.","family":"Watkins","sequence":"first","affiliation":[{"name":"Geriatric Research, Education, and Clinical Center; Durham VA Health Care System; Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-7481","authenticated-orcid":false,"given":"M. E.","family":"Gee","sequence":"additional","affiliation":[{"name":"Geriatric Research, Education, and Clinical Center; Durham VA Health Care System; Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-5948","authenticated-orcid":false,"given":"J. N.","family":"Brown","sequence":"additional","affiliation":[{"name":"Pharmacy Service; Durham VA Health Care System; Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,20]]},"reference":[{"key":"10.1111\/jcpt.12715-BIB0001|jcpt12715-cit-0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/head.12482","article-title":"The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies","volume":"55","author":"Burch","year":"2015","journal-title":"Headache"},{"key":"10.1111\/jcpt.12715-BIB0002|jcpt12715-cit-0002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1526-4610.2007.00990.x","article-title":"Direct cost burden among insured US employees with migraine","volume":"48","author":"Hawkins","year":"2008","journal-title":"Headache"},{"key":"10.1111\/jcpt.12715-BIB0003|jcpt12715-cit-0003","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the united states: disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12715-BIB0004|jcpt12715-cit-0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1111\/jcpt.12715-BIB0005|jcpt12715-cit-0005","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","article-title":"Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"key":"10.1111\/jcpt.12715-BIB0006|jcpt12715-cit-0006","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"key":"10.1111\/jcpt.12715-BIB0007|jcpt12715-cit-0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11916-003-0012-6","article-title":"The role of anticonvulsants in preventive migraine therapy","volume":"7","author":"Corbo","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"10.1111\/jcpt.12715-BIB0008|jcpt12715-cit-0008","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1756285611417920","article-title":"The cognitive impact of antiepileptic drugs","volume":"4","author":"Eddy","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"issue":"Suppl 2","key":"10.1111\/jcpt.12715-BIB0009|jcpt12715-cit-0009","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1111\/j.1528-1157.2000.tb01523.x","article-title":"Adverse effects of antiepileptic drugs","volume":"41","author":"Greenwood","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12715-BIB0010|jcpt12715-cit-0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4137\/JCNSD.S4365","article-title":"Topiramate: safety and efficacy of its use in the prevention and treatment of migraine","volume":"3","author":"Minton","year":"2011","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.1111\/jcpt.12715-BIB0011|jcpt12715-cit-0011","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1111\/jcpt.12715-BIB0012|jcpt12715-cit-0012","unstructured":"Topamax [Package Insert] Titusville NJ Janssen Pharmaceuticals, Inc 2009 https:\/\/www.topamax.com\/files\/topamax.pdf"},{"key":"10.1111\/jcpt.12715-BIB0013|jcpt12715-cit-0013","unstructured":"Depakote [Package Insert] AbbVie, Inc: North Chicago, IL 2017 http:\/\/www.rxabbvie.com\/pdf\/depakote.pdf"},{"key":"10.1111\/jcpt.12715-BIB0014|jcpt12715-cit-0014","unstructured":"Depakote ER [Package Insert] AbbVie, Inc: North Chicago, IL 2017 http:\/\/www.rxabbvie.com\/pdf\/dep3.pdf"},{"key":"10.1111\/jcpt.12715-BIB0015|jcpt12715-cit-0015","unstructured":"Depakene [Package Insert] AbbVie Inc: North Chicago, IL 2017 https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b4331f5-4475-417a-6a9d-09c2f8334235"},{"key":"10.1111\/jcpt.12715-BIB0016|jcpt12715-cit-0016","unstructured":"Levetiracetam Micromedex Solutions http:\/\/www.micromedexsolutions.com\/"},{"key":"10.1111\/jcpt.12715-BIB0017|jcpt12715-cit-0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the prisma statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12715-BIB0018|jcpt12715-cit-0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1526-4610.2004.04053.x","article-title":"Efficacy and safety of levetiracetam in pediatric migraine","volume":"44","author":"Miller","year":"2004","journal-title":"Headache"},{"key":"10.1111\/jcpt.12715-BIB0019|jcpt12715-cit-0019","first-page":"74","article-title":"Levetiracetam in the treatment of pediatric headache","volume":"9","author":"Awaad","year":"2014","journal-title":"J T U Med Sc"},{"key":"10.1111\/jcpt.12715-BIB0020|jcpt12715-cit-0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1526-4610.2007.00728.x","article-title":"Levetiracetam prophylaxis in pediatric migraine-an open-label study","volume":"47","author":"Pakalnis","year":"2007","journal-title":"Headache"},{"key":"10.1111\/jcpt.12715-BIB0021|jcpt12715-cit-0021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10194-003-0043-8","article-title":"An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine","volume":"4","author":"Gallai","year":"2003","journal-title":"J Headache Pain"},{"key":"10.1111\/jcpt.12715-BIB0022|jcpt12715-cit-0022","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","article-title":"Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study","volume":"29","author":"Brighina","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/jcpt.12715-BIB0023|jcpt12715-cit-0023","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WNF.0000000000000005","article-title":"Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India","volume":"36","author":"Verma","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/jcpt.12715-BIB0024|jcpt12715-cit-0024","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0972-2327.144290","article-title":"Comparison of levetiracetam and sodium valproate in migraine prophylaxis: a randomized placebo-controlled study","volume":"18","author":"Sadeghian","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1111\/jcpt.12715-BIB0025|jcpt12715-cit-0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/187152411794961086","article-title":"Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam","volume":"11","author":"Pizza","year":"2011","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1111\/jcpt.12715-BIB0026|jcpt12715-cit-0026","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.curtheres.2005.06.006","article-title":"Levetiracetam in the preventive treatment of transformed migraine: a prospective, open-label, pilot study","volume":"66","author":"Rapoport","year":"2005","journal-title":"Curr Ther Res"},{"key":"10.1111\/jcpt.12715-BIB0027|jcpt12715-cit-0027","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0333102410384886","article-title":"Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT])","volume":"31","author":"Beran","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1111\/jcpt.12715-BIB0028|jcpt12715-cit-0028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1574884712666170329094419","article-title":"Levetiracetam in compare to sodium valproate for prophylaxis in chronic migraine headache: a randomized double-blind clinical trial","volume":"12","author":"Kashipazha","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"10.1111\/jcpt.12715-BIB0029|jcpt12715-cit-0029","first-page":"Cd010610","article-title":"Topiramate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1111\/jcpt.12715-BIB0030|jcpt12715-cit-0030","first-page":"Cd010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12715-BIB0031|jcpt12715-cit-0031","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.yebeh.2003.09.007","article-title":"Use of levetiracetam in a population of patients aged 65\u00a0years and older: a subset analysis of the KEEPER trial","volume":"4","author":"Ferrendelli","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1111\/jcpt.12715-BIB0032|jcpt12715-cit-0032","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0404.2006.00657.x","article-title":"Levetiracetam: a long-term follow-up study of efficacy and safety","volume":"114","author":"Bauer","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/jcpt.12715-BIB0033|jcpt12715-cit-0033","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.2009.01257.x","article-title":"Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up","volume":"121","author":"Kuba","year":"2010","journal-title":"Acta Neurol Scand"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12715","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12715\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:56:50Z","timestamp":1720303010000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12715","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,20]]}}}